Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Oyster Point Pharma stock

Learn how to easily invest in Oyster Point Pharma stock.

Oyster Point Pharma Inc is a biotechnology business based in the US. Oyster Point Pharma shares (OYST) are listed on the NASDAQ and all prices are listed in US Dollars. Oyster Point Pharma employs 303 staff and has a trailing 12-month revenue of around $31.9 million.

How to buy shares in Oyster Point Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OYST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Oyster Point Pharma stock price (NASDAQ: OYST)

Use our graph to track the performance of OYST stocks over time.

Oyster Point Pharma shares at a glance

Information last updated 2022-09-25.
Latest market close$6.13
52-week range$3.46 - $19.98
50-day moving average $6.59
200-day moving average $8.59
Wall St. target price$28.60
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-4.95

Buy Oyster Point Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Oyster Point Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Oyster Point Pharma price performance over time

Historical closes compared with the close of $6.13 from 2022-09-27

1 week (2022-09-21) 2.51%
1 month (2022-08-26) -4.67%
3 months (2022-06-28) 31.26%
6 months (2022-03-25) -48.66%
1 year (2021-09-28) -48.92%
2 years (2020-09-28) -68.06%
3 years (2019-09-24) N/A
5 years (2017-09-24) N/A

Oyster Point Pharma financials

Revenue TTM $31.9 million
Gross profit TTM $23 million
Return on assets TTM -57.83%
Return on equity TTM -193.86%
Profit margin 0%
Book value $0.40
Market capitalisation $178.7 million

TTM: trailing 12 months

Oyster Point Pharma share dividends

We're not expecting Oyster Point Pharma to pay a dividend over the next 12 months.

Oyster Point Pharma share price volatility

Over the last 12 months, Oyster Point Pharma's shares have ranged in value from as little as $3.46 up to $19.98. A popular way to gauge a stock's volatility is its "beta".

OYST.US volatility(beta: 1.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oyster Point Pharma's is 1.0075. This would suggest that Oyster Point Pharma's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Oyster Point Pharma overview

Oyster Point Pharma, Inc. , a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey. .

Frequently asked questions

What percentage of Oyster Point Pharma is owned by insiders or institutions?
Currently 1.532% of Oyster Point Pharma shares are held by insiders and 88.694% by institutions.
How many people work for Oyster Point Pharma?
Latest data suggests 303 work at Oyster Point Pharma.
When does the fiscal year end for Oyster Point Pharma?
Oyster Point Pharma's fiscal year ends in December.
Where is Oyster Point Pharma based?
Oyster Point Pharma's address is: 202 Carnegie Center, Princeton, NJ, United States, 08540
What is Oyster Point Pharma's ISIN number?
Oyster Point Pharma's international securities identification number is: US69242L1061
What is Oyster Point Pharma's CUSIP number?
Oyster Point Pharma's Committee on Uniform Securities Identification Procedures number is: 69242L106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site